Media bungles open access details

Several news outlets keep misreporting the public access mandate of a congressional funding bill. As open access blogger Peter Suber linkurl:posted;http://www.earlham.edu/~peters/fos/2007/11/more-jam-about-nih-policy.html last week, Nature News, linkurl:The Washington Post;http://www.washingtonpost.com/wp-dyn/content/article/2007/10/31/AR2007103102668.html , the blog linkurl:Slashdot;http://science.slashdot.org/science/07/11/07/2318208.shtml, and several others all reported that a provision in the congressional appropriations bill for 2008 would require NIH-funded researchers to publish in open access journals. On November 7, Nature News linkurl:reported;http://www.nature.com/news/2007/071107/full/450148a.html: "US investigators funded by the National Institutes of Health (NIH) may soon be compelled to publish only in journals that make their research papers freely available within one year of publication." What the bill actually says is that all NIH-funded research must be deposited in PubMed within one year of publication. There was a push to eliminate or alter this requirement in the bill last month, as I reported linkurl:here;http://www.the-scientist.com/blog/display/53746/, but those amendments did not pass. This bill was linkurl:vetoed;http://www.the-scientist.com/blog/display/53855/ today (November 13) by President Bush for its high spending level, but has been sent back to Capitol Hill for a vote to override the veto. Suber coined this common error made by media, agencies, and government JAM, or Journal-Archive Mixup. He has been tracking its occurrence for more than three years.

Media bungles open access details

The Scientist ARCHIVES

Become a Member of

Meet the Author

Andrea Gawrylewski

Related Research Resources

Why Do Some People Get Drunk Faster Than Others?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Sex Differences in Neurological Research

New Frontiers in Vaccine Development

New Approaches for Decoding Cancer at the Single-Cell Level

Organoids as a Tool for Tissue Regeneration Research

Products

Product News

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Accelerating Mycoplasma Testing for Targeted Therapy Development